|
Immunotherapy
Citations 11-20 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Impaired T-cell priming in vivo resulting from dysfunction of WASp-deficient dendritic cells
- Gerben Bouma, Siobhan Burns, and Adrian J. Thrasher
Blood 2007; 110: 4278-4284.
[Abstract]
[Full text]
[PDF]
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity
- Jens Dannull, Diem-Thu Lesher, Robert Holzknecht, Wenning Qi, Gabi Hanna, Hilliard Seigler, Douglas S. Tyler, and Scott K. Pruitt
Blood 2007; 110: 4341-4350.
[Abstract]
[Full text]
[PDF]
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia
- Eduardo Olavarria, Shamyla Siddique, Michael J. Griffiths, Sharon Avery, Jenny L. Byrne, Karen P. Piper, Anne L. Lennard, Lalit Pallan, Julie M. Arrazi, Jolanta B. Perz, Derville O'Shea, John M. Goldman, Jane F. Apperley, and Charles F. Craddock
Blood 2007; 110: 4614-4617.
[Abstract]
[Full text]
[PDF]
Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade
- Wei Yu Lin, Qian Gong, Dhaya Seshasayee, Zhonghua Lin, Qinglin Ou, Shiming Ye, Eric Suto, Jean Shu, Wyne Pun Lee, Ching-Wei V. Lee, Germaine Fuh, Maya Leabman, Suhasini Iyer, Kathy Howell, Thomas Gelzleichter, Joseph Beyer, Dimitry Danilenko, Sherry Yeh, Laura E. DeForge, Allen Ebens, Jeffrey S. Thompson, Christine Ambrose, Mercedesz Balazs, Melissa A. Starovasnik, and Flavius Martin
Blood 2007; 110: 3959-3967.
[Abstract]
[Full text]
[PDF]
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
- Peter Hillmen, Petra Muus, Ulrich Dührsen, Antonio M. Risitano, Jörg Schubert, Lucio Luzzatto, Hubert Schrezenmeier, Jeffrey Szer, Robert A. Brodsky, Anita Hill, Gerard Socié, Monica Bessler, Scott A. Rollins, Leonard Bell, Russell P. Rother, and Neal S. Young
Blood 2007; 110: 4123-4128.
[Abstract]
[Full text]
[PDF]
Selecting highly affine and well-expressed TCRs for gene therapy of melanoma
- Annelies Jorritsma, Raquel Gomez-Eerland, Maarten Dokter, Willeke van de Kasteele, Yvonne M. Zoet, Ilias I. N. Doxiadis, Nathalie Rufer, Pedro Romero, Richard A. Morgan, Ton N. M. Schumacher, and John B. A. G. Haanen
Blood 2007; 110: 3564-3572.
[Abstract]
[Full text]
[PDF]
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
- Mary T. Litzinger, Romaine Fernando, Tyler J. Curiel, Douglas W. Grosenbach, Jeffrey Schlom, and Claudia Palena
Blood 2007; 110: 3192-3201.
[Abstract]
[Full text]
[PDF]
Prevention of graft-versus-host disease by anti–IL-7R antibody
- Brile Chung, Eric P. Dudl, Dullei Min, Lora Barsky, Nancy Smiley, and Kenneth I. Weinberg
Blood 2007; 110: 2803-2810.
[Abstract]
[Full text]
[PDF]
Cellular immune therapy for chronic lymphocytic leukemia
- Arnon P. Kater, Marinus H. J. van Oers, and Thomas J. Kipps
Blood 2007; 110: 2811-2818.
[Abstract]
[Full text]
[PDF]
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
- Catherine M. Bollard, Stephen Gottschalk, Ann M. Leen, Heidi Weiss, Karin C. Straathof, George Carrum, Mariam Khalil, Meng-fen Wu, M. Helen Huls, Chung-Che Chang, M. Victoria Gresik, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, and Helen E. Heslop
Blood 2007; 110: 2838-2845.
[Abstract]
[Full text]
[PDF]
|
|
